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Abstract
Background: One of the most commonly used molecular test for malaria diagnosis is the polymerase chain
reaction (PCR)-based amplification of the 18S ribosomal DNA (rDNA) gene. Published diagnostic assays based on
the 18S gene include the “gold standard” nested assay, semi-nested multiplex assay, and one tube multiplex assay.
To our knowledge, no one has reported whether the two multiplex methods are better at detecting mixed
Plasmodium infections compared to the nested assay using known quantities of DNA in experimentally mixed
cocktails.
Findings: Here we evaluated three PCR assays (nested, semi-nested multiplex, and one-tube multiplex) for the
simultaneous detection of human malaria parasites using experimentally mixed cocktails of known quantities of
laboratory derived DNA. All three assays detected individual species with high sensitivity and specificity when DNA
was from any one single species; however, experimentally mixed DNA cocktails with all four species present were
correctly identified most consistently with the nested method. The other two methods failed to consistently
identify all four species correctly, especially at lower concentrations of DNA -subclinical levels of malaria (DNA
equivalent to or less than 10 parasites per microliter).
Conclusions: The nested PCR method remains the method of choice for the detection of mixed malaria infections
and especially of sub-clinical infections. Further optimization and/or new molecular gene targets may improve the
success rate of detecting multiple parasite species simultaneously using traditional PCR assays.
Findings
Approximately 2 billion people are exposed to malaria
with an estimated 250 million clinical cases and about
800,000 deaths annually [1,2]. Four Plasmodium species
are known to cause malaria in humans: P. falciparum,
P. vivax, P. malariae and P. ovale. Many malaria ende-
mic regions report mixed infections of these species and
the prevalence of mixed infections varies depending on
the geographic region. For example, within India,
Hamer et al. [3] reported 9.3% of malaria cases as mixed
P. falciparum/P. vivax infection and Rasheed et al. [4]
reported 18% of cases were P. falciparum/P. vivax
mixed infection. The clinical presentation of malaria is
often nonspecific; consequently many febrile illnesses
with unknown etiology are attributed to malaria
(resulting in presumptive diagnosis and treatment).
Therefore, appropriate laboratory tools are critical for
the prompt diagnosis and treatment of malaria. This is
especially true for mixed infections which are often not
recognized, and as a result, have been underestimated
(reviewed in [5] and [6]).
Existing tools for the diagnosis of malaria include
microscopy, rapid diagnosis tests (RDTs) and molecular
tools (reviewed in [7]). For over a century, microscopy
has remained the standard for malaria detection and spe-
cies determination in many endemic areas. It is relatively
inexpensive and allows for the quantification of parasite-
mia. However, several challenges exist in performing
microscopic diagnosis for routine clinical use, especially
in malaria endemic countries, including limited availabil-
ity of well trained microscopists, lack of infrastructure
(such as power supply) and training, and the possibility
of misdiagnosis due to low parasitemia or mixed infec-
tions, even with experienced microscopists [8,9]. Further-
more, microscopy may not consistently detect all
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dium knowlesi (a monkey malaria recently discovered to
also infect humans) has been falsely diagnosed as Plasmo-
dium malariae using routine microscopy, and only
through the use of a molecular method was this species
correctly identified in humans [11].
RDTs are immunochromatographic tests designed to
detect parasite products in human blood. Currently, the
two most common RDTs use histidine rich protein-2
(HRP-2) or lactose dehydrogenase (LDH) as target pro-
teins for detection [12]. RDTs are increasingly being
used for malaria diagnosis because they are rapid and
easier to use especially in resource limited settings.
Good quality RDTs are generally as sensitive as micro-
scopy in detecting P. falciparum (about 100 parasites
per microliter) but they are much less sensitive in iden-
tifying other species of malaria parasites. Because RDTs
are only qualitative tests, the density of parasitemia can-
not be accurately determined. Additionally, RDTs can
result in false positives since antigen persists up to one
month after the clearance of parasites.
Molecular methods are proving to be useful in species
identification and accurate detection of mixed species
infections in addition to the detection of subclinical
infections [13]. As we move towards malaria elimina-
tion/eradication phases, tools to detect sub-clinical levels
of infections will aid in malaria control programs. How-
ever, the use of molecular tools is hampered by some
factors, including high cost of initial equipment setup
and the inability to obtain reagents due to infrastructure
in many field settings. Additionally traditional molecular
methods can be labor intensive and may be prone to
amplicon contamination thus requiring advanced techni-
cal knowledge. The most commonly used molecular test
for malaria diagnosis is the polymerase chain reaction
(PCR) -based amplification of the 18S ribosomal DNA
(rDNA) gene which allows detection of the different
species of human malaria parasites based on different
sized PCR products [14-21]. The nested PCR method
developed by Snounou et al [20] has been widely used
in laboratory studies and in clinical diagnosis, including
in a reference diagnostic laboratory in the United States
[13,15,17,22]. However, this method is time consuming,
expensive, and labor intensive as it requires five separate
PCR reactions to detect P. falciparum, P. vivax, P. ovale,
and P. malariae. Sequence variation in strains of
P. ovale have recently been shown to affect the ability of
the nested Snounou primers to identify variants of
P. ovale, leading to the development of new primers for
this species in the nested PCR assay [23]. Alternative
multiplex approaches have been developed including a
semi-nested multiplex [18] and single round multiplex
PCR [16] in an effort to simplify this method, both of
which target a region of the 18S gene thus far not
shown to vary within individual species specific strains
of Plasmodium [23]. The semi-nested multiplex PCR
[18] utilizes a universal 18S rDNA reverse primer and
two forward 18S rDNA primers, one specific to the
Plasmodium genus and one specific to all mammalian
18S rDNA. The primary Plasmodium genus specific for-
ward primer and four species specific reverse primers
are used in the secondary reaction. The authors claim
that the sensitivity of the semi-nested multiplex is
equivalent to detecting 0.1 parasites/μl( p / μl) in an
experimentally mixed P. falciparum/P. malariae DNA
cocktail, and indicate that the method confirmed micro-
scopically identified coinfections in field samples. The
single round multiplex [16] utilizes a Plasmodium genus
specific reverse primer with four forward species specific
primers. Padley et al. [16] claim the sensitivity of the
assay to be 0.02 and 0.004 p/μlf o rP. falciparum and
P. ovale, respectively, and did not test sensitivity of the
assay for P. vivax and P. malariae. Additionally they
claim the assay was able to detect all four species in
simulated mixed coinfections; however the data is only
shown for P. vivax/P. falciparum coinfections. In addi-
tion to traditional PCR-based molecular tools, real-time
PCR has recently been shown to be a robust alternative
for malaria diagnosis. However, several factors inhibit
the use of this method in malaria endemic regions
including cost, lack of infrastructure, and lack of techni-
cal support due to infrastructure problems. Additionally,
false negatives for Plasmodium species remain a pro-
blem with the current real time assays due to sequence
variation and competitive inhibition [24].
The role of molecular tools for the detection of
malaria parasites, and especially the detection of mixed
infections, is becoming clear [25] and reviewed in [5].
The three previously described PCR-based methods
(nested, semi-nested, and single-tube multiplex) are all
good alternatives to microscopy and RDTs. However, to
our knowledge, no one has evaluated which of these tra-
ditional PCR methods is truly better at detecting mixed
Plasmodium infections; therefore, we compared the two
multiplex methods to the nested method using known
quantities of laboratory derived Plasmodium DNA alone
and in experimentally mixed cocktails containing all
four species of DNA.
Methods
Parasite culture and DNA extraction
DNA was extracted from laboratory cultured P. falci-
parum (3D7) and from monkey derived P. vivax (SV4),
P. malariae (Uganda I), and P. ovale (Nigeria I) using a
QIAamp DNA Mini Kit (QIAGEN, Valencia, CA),
according to the recommendations by the manufacturer.
Thin smears were prepared, stained, and counted for
each of the species to determine the percentage
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per microliter was then determined for each species
using a coulter counter and the number of malaria
infected RBCs per microliter (p/uL) was calculated using
the formula below:
Parasite L total number of RBC L Percentage parasitemia //  
DNA was isolated from a total of 8 × 10
6 parasites for
each species and suspended in 200 μl of sterile TE;
therefore, 1 μl of sample contained the DNA equivalent
of 40,000 parasites. The stock DNA was aliquoted and
stored at -20°C, from which seven 10-fold serial dilu-
tions were prepared up to a final concentration equiva-
lent of 0.04 parasite genomes/μl. Assay limits of
detection of individual Plasmodium species and detec-
tion of multiple species from mixed DNA cocktails were
evaluated over seven replicates. Experimentally mixed
cocktails were made using two μle a c ho fp a r a s i t eD N A
of varying initial concentrations (Table 1). One microli-
ter of the mixture was then used in a 20 μl PCR reac-
tion, equivalent to the final parasitemias of each species
given in Additional file 1. Because the field of mixed
infections is one that has received little attention
(mainly due to diagnosis issues), the DNA ratios for the
mixed cocktails were chosen to both, represent low
levels of infection, which are commonly missed by
microscopy [5,6,25,26], and to simulate varying combi-
nations of mixed infections. In general, equimolar
amounts of each species rarely occur in the field, and it
is common for one species in the mixed infections to
predominate (reviewed in [25]).
All PCR assays were completed on a BioRad iCycler
(BioRad, Hercules, CA). Nested PCR was performed with
primers and cycling conditions described by Snounou et
al. [20] with modifications described in [27] in a 20 μl
reaction containing 1× buffer, 2.5 mM MgCl2, 200 μM
dNTPs, 200 nM primers, and 1.25 units of Taq Polymer-
ase (New England Biolabs, Ipswich, MA). The multiplex
semi-nested and multiplex single round PCRs were per-
formed in 20 μl reaction using Promega Taq PCR Master
Mix (Promega, Madison, WI), per manufacturer’s
instructions. Multiplex semi-nested PCR was performed
with primers described by Rubio et al. [18], modifying
the annealing temperatures to 55°C for the primary reac-
tion and 58°C for the nested reaction. The multiplex
single round PCR was performed using primers and
cycling conditions described by Padley et al. [16] with the
addition of an extension step for one minute at 72°C. No
template control (water) was run in each experiment.
Five microliters (5 μl) of PCR product were visualized in
2% agarose gel stained with ethidium bromide.
Results and Discussion
The nested PCR assay was able to detect single Plasmo-
dium species infections down to 0.4 p/μl (Figure 1A-D).
The semi-nested multiplex assay was as sensitive as the
nested assay at detecting P. falciparum and P. vivax,
more sensitive at detecting P. malariae (0.04p/μL), and
was only able to detect down to 4 p/μL for P. ovale (Fig-
ure 1I-L). The limit of detection for the multiplex single
round protocol was comparable to the other protocols
for P. falciparum, but was only able to detect down to
4p / μlf o rP. ovale and 40 p/μlf o rP. malariae
and P. vivax, a 100-fold difference in sensitivity
(Figure 1E-H). Our levels of detection for P. falciparum
in a singly infected sample are comparable to those
reported by Rubio et al. [18] (0.1 p/μl), while sensitivity
was greater than reported by Rubio et al. [18] for
P. malariae (0.1 p/μl), and much less sensitive than
reported by Padley [16] for P. falciparum (0.02 p/μl)
and P. ovale (0.004 p/μl). Because we had to rely on
parasite counts to determine our initial concentrations
for the species for which we are unable to culture
(i.e. P. vivax, P. ovale,a n dP. malariae), equal p/μlm a y
not contain equal amounts of DNA due to the presence
of schizonts, thus affecting our ability to replicate the
sensitivity results previously reported by these authors.
The accuracy of each method to detect all four human
Plasmodium species in experimentally mixed infections
was assessed over seven replicates. Only the nested PCR
assay consistently detected all four species in the cock-
tails at the sensitivity levels reported for singly infected
Table 1 Preparation of mock mixed infections
Well # P. falciparum P. malariae P. ovale P. vivax
Concentration in Parasites/μL
1 400 40 400 40
2 40 40 400 40
34 0 4 0 4 0 4 0
44 0 4 0 4 4 0
5 4 40 4 40
64 4 0 4 4
7 40 400 40 40
8 4 400 4 40
9 400 40 400 400
10 40 40 4 400
11 40 4 4 40
12 400 40 40 400
13 (F) 400 - - -
14 (M) - 400 - -
15 (O) - - 400 -
16 (V) - - - 400
17 (N) - - - -
Mock mixed infections were prepared as shown. 2 ul of each species was
mixed with equal volumes of the other species as shown. One microliter of
each mixture was then used for the PCR assay.
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assay is more labor intensive than the other two meth-
ods, requiring five sets of PCR reactions for systematic
detection of all four parasites.
The semi-nested multiplex method detected at best,
three of the four species simultaneously (P. falciparum
and P. vivax and either P. malariae or P. ovale,d e p e n d -
ing on concentration) as shown in Figure 2C (*) to as low
as 10 p/μl. The assay was able to detect parasite concen-
trations as low as one p/μl in certain mixing schemes, in
agreement with our level of sensitivity found for this
assay for singly infected samples. In the mixed DNA
cocktails, the semi-nested PCR assay was less sensitive in
amplifying P. falciparum and P. vivax consistently (Figure
2 and Additional file 1). This method was successful in
amplifying P. falciparum DNA 4/7 times in any of the
cocktail combinations tested. The assay performed
slightly better with P. vivax, correctly identifying the spe-
cies 6/7 times when parasitemia was 100 p/μl. At lower
parasitemias, the ability of the semi-nested assay seemed
to depend on the proportion of P. vivax to P. ovale.F o r
instance, when P. vivax and P. ovale were present in the
mixture at 10 p/μl each, the assay correctly identified
P. vivax 4/7 times (Additional file 1), but 5/7 or 6/7 times
if P. ovale was present at one p/μl. It appears that the
performance of this method in amplifying P. vivax DNA
was negatively affected whenever the concentration of
P. ovale was higher than P. vivax (as noted in the failure
of this assay to detect P. vivax when the ratio of P. ovale
DNA to P. vivax DNA was 100:10 p/μl, Additional file 1).
The assay performed quite well in amplifying P. malariae
and P. ovale in mixed DNA cocktails, generally detecting
these species greater than 50% of the time (Table 1).
Occasionally, we were able to amplify all the four species
but this was not consistent (2/7 times this method ampli-
fied all four species for the mixed DNA cocktail contain-
ing 10, 10, 1, 10 p/μl and 1/7 times in the cocktail
containing 100, 10, 10, 100 p/μlo fP. falciparum,
P .m a l a r i a e ,P .o v a l e ,a n dP .v i v a x ). We had better
success at amplifying three species simultaneously as
shown in Figure 2C (*). Because the assay performs well
for samples infected with only one species of Plasmo-
dium, it is likely that competition for primers contributed
to the inability to amplify all four species of Plasmodium
simultaneously; therefore, in instances where multiple
species of Plasmodium are suspected, the method can be
run with only individual species specific primers to
increase the specificity of the assay.
The one tube multiplex was the least sensitive, detect-
i n ga tm o s to n l yt w os p e c i e ss i m u l t a n e o u s l yi nt h e
mock mixed infections (Figure 2B). The assay correctly
identified P. falciparum most consistently in the mixed
DNA cocktails; however, it was especially poor at
detecting P. malariae and P. vivax, correctly identifying
these species less than 50% of the time (Additional file
1). This method performed reasonably well in identify-
ing P. ovale, especially when the concentration of this
DNA was equal to or greater than 10 p/μl, in agreement
with the level of sensitivity found in the singly infected
samples. We were able to detect 1 p/uL of P. ovale in
the mixed mock infections using the semi-nested assay
22/42 times and the single tube multiplex 7/42 times,
which is within an order of magnitude of the level of
detection we found for single infections (4 p/uL).
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Multiplex PCR  Semi-nested PCR 
205bp 
144bp 
800bp 
120bp 
276bp 
412bp 
385bp 300bp 
395bp 269bp 
436bp 499bp 
A  B 
C  D 
E  F 
G  H 
I  J 
K  L 
Figure 1 Limits of detection of the three different methods at detecting the four Plasmodium species. 10-fold serial dilutions of all four
species were prepared starting from 40,000p/μl stock. Lane 1 = 40, 000p/μL, 2 = 4,000p/μL, 3 = 400p/μL, 4 = 40p/μL, 5 = 4p/μL 6 = 0.4p/μL
and 7 = 0.04p/μL. One microliter of each of these dilutions was amplified as per the different protocols. Representative gels are shown for the
nested (Snounou) (A-D), multiplex (Padley) (E-H), and semi-nested (Rubio) (I-L) results. The nested PCR was able to amplify up to 0.4p/μL for each
of the species. The multiplex method amplified up to 0.4 p/μL for P. falciparum,4p / μLo fP. ovale and 40p/μL of both P. malariae and P. vivax
while the semi-nested PCR amplified up to 0.04p/μL for P. malariae, 0.4p/μL for both P. falciparum and P. vivax and 4p/μL for P. ovale. L: 100 bp
molecular weight marker.
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expected concentration of parasites in the mock mixed
infections for multiplex single tube assays for P. vivax
(less than 40 p/uL, 9/54 times), which was most prob-
ably by chance only. Competition between the primer
pairs likely contributed to the inconsistencies of the
semi-nested multiplex and single tube multiplex meth-
ods to correctly identify multiply infected samples.
Cost of each assay was calculated and included the price
of reagents and plastic consumables (tips, tubes, etc.) for a
single sample. The nested method was the most expensive
(8 USD/sample), followed by the semi-nested method
(5 USD/sample), and single tube multiplex (4 USD/sample).
Clearly the nested PCR method is the best PCR-based
assay for the diagnosis of mixed infections and of subcli-
nical infections among the three methods tested in this
study. However, researchers should be aware of the
sequence variability within strains of P. ovale,a n dt h u s
utilize the primers for this species as described in [23].
Many of the inhabitants of high malaria endemic regions
may harbor high levels of malaria parasites with no clini-
cal symptoms (subclinical/asymptomatic infections)
mainly due to acquired partial immunity. These infec-
tions are commonly missed by microscopy and RDT
which usually detect 50-100 p/uL at best. As we move
towards the malaria elimination/eradication phases
P. ovale
P. vivax
L   1    2   3   4   5   6    7   8   9 10 11 12  F   M  O   V
L  1    2   3   4   5    6   7   8    9 10  11 12  F   M  O   V 
P. ovale
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L   1    2   3   4   5   6    7   8   9 10 11 12  F   M  O   V
L  1    2   3   4   5    6   7   8    9 10  11 12  F   M  O   V 
L   1   2   3   4   5   6   7   8   9  L  10 11 12  F  M  O  V  N
L   1   2   3   4   5   6   7   8   9   L  10 11 12  F  M  O   V  N
P. falciparum
P. malariae
L   1   2   3   4   5   6   7   8   9  L  10 11 12  F  M  O  V  N
L   1   2   3   4   5   6   7   8   9   L  10 11 12  F  M  O   V  N
P. falciparum
P. malariae
144 bp 
205 bp 
L    1      2    3    4     5    6     7     8     9   10   11  12    F    M    O    V   N    
F
M O
V
L    1      2    3    4     5    6     7     8     9   10   11  12    F    M    O    V   N    
F
M O
V
100 bp 
600 bp 
L    1     2     3    4    5    6    7     8     9   10  11   12 F   M    O    V    N  SL
F
M
O V ** *
L    1     2     3    4    5    6    7     8     9   10  11   12 F   M    O    V    N  SL
F
M
O V
L    1     2     3    4    5    6    7     8     9   10  11   12 F   M    O    V    N  SL
F
M
O V ** *
100 bp 
600 bp 
120 bp 
800 bp  
A
B
C
Figure 2 Detection of mock mixed infections using the three different methods. Mock mixed infections were prepared as per Table 1. One
microliter of each of the mock mixed infection was amplified according to the different protocols resulting in the final parasite concentrations
given by Additional file 1. Representative gels are shown for the nested (Snounou) (A), multiplex (Padley) (B), and semi-nested (Rubio) (C). Lane
numbers correspond to the lanes as shown in Additional file 1. F: P. falciparum,M :P. malariae,O :P. ovale,V :P. vivax, L: 100 bp molecular weight
marker, SL: Species Ladder created by mixing equal amounts of individually amplified species DNA using Rubio primers.
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tions will be common due to an increase in intervention
programs; therefore, tools to detect sub-clinical levels of
infections will be critical to determine the success of
malaria control programs. Only molecular tools have
been shown to accurately detect subclinical levels of
infections. In this study, the nested PCR method, though
tedious in nature, was the only method that consistently
and accurately detected these levels. In addition, mixed
infections have often been unrecognized or underre-
ported [5,6,25,26] mainly due to limited detection tools
[25]. Indeed, the use of molecular tools for malaria diag-
nosis has revealed that low-level mixed infections are
common [26]. Further optimization of primers and reac-
tion conditions could possibly improve the semi-nested
and multiplex methods. This study suggests that diagnos-
tic assays need to be given careful consideration before
use in clinical diagnostic settings due to the probability
of a high number of false negatives if these two multiplex
methods are used. In areas where there are few species
circulating, the semi-nested assay may be an acceptable
assay; however, in areas where many species are circulat-
ing, the nested PCR assay would be the most appropriate
diagnostic assay of these three. Alternative molecular
methods using real time PCR [28,29] and loop mediated
isothermal amplification (LAMP) [30-32] assays have
been reported and further evaluation of these newer
methods will be necessary to determine their utility for
malaria diagnosis in the field. It is important to note that
in at least one real time PCR 18S assay, it has been
shown that if there is a greater than 10 fold difference in
the parasitemia in a mixed infection, the species with the
greater concentration of DNA will be the only species
detected [24]. In addition, no reports have been made, to
date, of multiplex-LAMP assays. Further research to
develop simpler and field-usable molecular tools will
enhance prompt and accurate diagnosis of malaria in
endemic regions. The release of the whole genomes of
P. falciparum and P. vivax should enable the identifica-
tion of potential unique species-specific molecular targets
to overcome some of the limitations associated with the
existing multiplex molecular tools.
Additional file 1: The success rate of each assay in detecting
P. falciparum, P. malariae, P. ovale,a n dP. vivax at the varying
parasite concentration within mock-mixed infections. The nested and
multiplex semi-nested PCR assay was replicated seven times for each of
the mock-mixed infections, while only six replications were considered
for the multiplex single round due to lack of amplification of the positive
controls in one replication.
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